(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes
Background: Pancreatic Islets of Langerhans are heterogeneous tissues consisting of multiple endocrine cell types that carry out distinct yet coordinated roles to regulate blood glucose homeostasis. Islet dysfunction and specifically failure of the beta cells to secrete adequate insulin are known pr...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877819305629 |
id |
doaj-7182bfcd1d5a41c19dc126dcb6bd0ee4 |
---|---|
record_format |
Article |
spelling |
doaj-7182bfcd1d5a41c19dc126dcb6bd0ee42020-11-24T21:36:01ZengElsevierMolecular Metabolism2212-87782019-09-0127S15S24(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetesNathan Lawlor0Michael L. Stitzel1The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USAThe Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA; Department of Genetics and Genome Sciences, University of Connecticut, Farmington, CT, 06032, USA; Institute for Systems Genomics, University of Connecticut, Farmington, CT, 06032, USA; Corresponding author. 10 Discovery Drive, Farmington, CT, 06032, USA.Background: Pancreatic Islets of Langerhans are heterogeneous tissues consisting of multiple endocrine cell types that carry out distinct yet coordinated roles to regulate blood glucose homeostasis. Islet dysfunction and specifically failure of the beta cells to secrete adequate insulin are known precursors to type 2 diabetes (T2D) onset. However, the exact genetic, (epi)genomic, and environmental mechanisms that contribute to islet failure, and ultimately to T2D pathogenesis, require further elucidation. Scope of review: This review summarizes efforts and advances in dissection of the complex genetic underpinnings of islet function and resilience in T2D pathogenesis. In this review, we will highlight results of the latest T2D genome-wide association study (GWAS) and discuss how these data are being combined with clinical measures in patients to uncover putative T2D subtypes and with functional (epi)genomic studies in islets to understand the genetic programming of islet cell identity, function, and adaptation. Finally, we discuss new and important opportunities to address major knowledge gaps in our understanding of islet (dys)function in T2D risk and progression. Major conclusions: Genetic variation exerts clear effects on the islet epigenome, regulatory element usage, and gene expression. Future (epi)genomic comparative analyses between T2D and normal islets should incorporate genetics to distinguish patient-specific from disease-specific differences. Incorporating genotype information into future analyses and studies will also enable more precise insights into the molecular genetics of islet deficiency and failure in T2D risk, and should ultimately contribute to a stratified view of T2D and more precise treatment strategies. Islet cellular heterogeneity continues to remain a challenge for understanding the associations between islet failure and T2D development. Further efforts to obtain purified islet cell type populations and determine the specific genetic and environmental effects on each will help address this. Beyond observation of islets at steady state conditions, more research of islet stress and stimulation responses are needed to understand the transition of these tissues from a healthy to diseased state. Together, focusing on these objectives will provide more opportunities to prevent, treat, and manage T2D. Keywords: Type 2 diabetes, Pancreatic islets, (Epi)genomics, Genetics, Environment, Dysfunctionhttp://www.sciencedirect.com/science/article/pii/S2212877819305629 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nathan Lawlor Michael L. Stitzel |
spellingShingle |
Nathan Lawlor Michael L. Stitzel (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes Molecular Metabolism |
author_facet |
Nathan Lawlor Michael L. Stitzel |
author_sort |
Nathan Lawlor |
title |
(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes |
title_short |
(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes |
title_full |
(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes |
title_fullStr |
(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes |
title_full_unstemmed |
(Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes |
title_sort |
(epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes |
publisher |
Elsevier |
series |
Molecular Metabolism |
issn |
2212-8778 |
publishDate |
2019-09-01 |
description |
Background: Pancreatic Islets of Langerhans are heterogeneous tissues consisting of multiple endocrine cell types that carry out distinct yet coordinated roles to regulate blood glucose homeostasis. Islet dysfunction and specifically failure of the beta cells to secrete adequate insulin are known precursors to type 2 diabetes (T2D) onset. However, the exact genetic, (epi)genomic, and environmental mechanisms that contribute to islet failure, and ultimately to T2D pathogenesis, require further elucidation. Scope of review: This review summarizes efforts and advances in dissection of the complex genetic underpinnings of islet function and resilience in T2D pathogenesis. In this review, we will highlight results of the latest T2D genome-wide association study (GWAS) and discuss how these data are being combined with clinical measures in patients to uncover putative T2D subtypes and with functional (epi)genomic studies in islets to understand the genetic programming of islet cell identity, function, and adaptation. Finally, we discuss new and important opportunities to address major knowledge gaps in our understanding of islet (dys)function in T2D risk and progression. Major conclusions: Genetic variation exerts clear effects on the islet epigenome, regulatory element usage, and gene expression. Future (epi)genomic comparative analyses between T2D and normal islets should incorporate genetics to distinguish patient-specific from disease-specific differences. Incorporating genotype information into future analyses and studies will also enable more precise insights into the molecular genetics of islet deficiency and failure in T2D risk, and should ultimately contribute to a stratified view of T2D and more precise treatment strategies. Islet cellular heterogeneity continues to remain a challenge for understanding the associations between islet failure and T2D development. Further efforts to obtain purified islet cell type populations and determine the specific genetic and environmental effects on each will help address this. Beyond observation of islets at steady state conditions, more research of islet stress and stimulation responses are needed to understand the transition of these tissues from a healthy to diseased state. Together, focusing on these objectives will provide more opportunities to prevent, treat, and manage T2D. Keywords: Type 2 diabetes, Pancreatic islets, (Epi)genomics, Genetics, Environment, Dysfunction |
url |
http://www.sciencedirect.com/science/article/pii/S2212877819305629 |
work_keys_str_mv |
AT nathanlawlor epigenomicheterogeneityofpancreaticisletfunctionandfailureintype2diabetes AT michaellstitzel epigenomicheterogeneityofpancreaticisletfunctionandfailureintype2diabetes |
_version_ |
1725942733934166016 |